Genomize
Genomize is a biotech startup specializing in genome-level data analysis, leveraging bioinformatics expertise to develop cutting-edge technologies. Their SEQ Platform offers comprehensive Next Generation Sequencing (NGS) data analysis and ACMG classification, providing clinicians and researchers with actionable insights to improve patient outcomes. Key features include AI-driven variant prioritization for accurate diagnosis, building real-time genotype/phenotype databases, somatic analysis for cancer treatment options, and robust bioinformatics pipelines for variant and CNV detection. They emphasize increasing diagnosis rates, empowering data control, and identifying treatment options for cancer patients. Genomize serves hundreds of hospitals and laboratories, aiming to deliver scientific excellence, continuous learning, and accessible, affordable services with expert customer support.
Genomize
Genomize is a biotech startup specializing in genome-level data analysis, leveraging bioinformatics expertise to develop cutting-edge technologies. Their SEQ Platform offers comprehensive Next Generation Sequencing (NGS) data analysis and ACMG classification, providing clinicians and researchers with actionable insights to improve patient outcomes. Key features include AI-driven variant prioritization for accurate diagnosis, building real-time genotype/phenotype databases, somatic analysis for cancer treatment options, and robust bioinformatics pipelines for variant and CNV detection. They emphasize increasing diagnosis rates, empowering data control, and identifying treatment options for cancer patients. Genomize serves hundreds of hospitals and laboratories, aiming to deliver scientific excellence, continuous learning, and accessible, affordable services with expert customer support.